Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion type Assertion NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_head.
- NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion description "[Pharmacological inhibition of the IL-1?, c-Jun N-terminal kinase, MCP-1, or matrix metalloprotease-2 signaling via spinal administration has been shown to attenuate inflammatory, neuropathic, or cancer pain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_provenance.
- NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion evidence source_evidence_literature NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_provenance.
- NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion SIO_000772 20880510 NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_provenance.
- NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion wasDerivedFrom befree-2016 NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_provenance.
- NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_assertion wasGeneratedBy ECO_0000203 NP842622.RAgKDjc0WzEvMRcNzcWP6Xs48Z-ag5VZKIlfBmQb3MZx4130_provenance.